TrademarkDir
OPSIS THERAPEUTICS
LIVE

Serial Number

90027853

Owner

Opsis Therapeutics, LLC

Attorney

Jason M. Hunt

First Use Date

May 4, 2024

Filing Date

Jun 30, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OPSIS THERAPEUTICS Trademark

Serial Number: 90027853 • Registration: 7434279

OPSIS THERAPEUTICS is a trademark filed by Opsis Therapeutics, LLC on June 30, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Opsis Therapeutics, LLC (2 trademarks)

525 Science Drive
Madison, WI 53711

Entity Type: 16

Trademark Details

Filing Date

June 30, 2020

Registration Date

July 2, 2024

First Use Anywhere

May 4, 2024

First Use in Commerce

May 4, 2024

Published for Opposition

March 30, 2021

Goods & Services

Biological preparations derived from human stem cells for the treatment of ocular disorders; living tissue grafts for surgical implantation for the treatment of ocular disorders

Implants comprising natural, non-living materials derived from human stem cells useful for treatment of ocular disorders, namely, non-living tissue grafts for surgical implantation

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 2, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 2, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 24, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 24, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 13, 2024 SUPC
USE AMENDMENT FILED
May 9, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
May 9, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2024 EXRA
SOU EXTENSION 5 GRANTED
Feb 14, 2024 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 13, 2024 AITU
NOTICE OF REVIVAL - E-MAILED
Dec 28, 2023 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Dec 28, 2023 TPEX
NOTICE OF REVIVAL - E-MAILED
Dec 28, 2023 NREV
PETITION TO REVIVE-GRANTED
Dec 28, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Dec 28, 2023 PROA
SOU EXTENSION 5 FILED
Nov 27, 2023 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 30, 2023 EXRA
SOU EXTENSION 4 GRANTED
Mar 28, 2023 EX4G
SOU EXTENSION 4 FILED
Mar 28, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 28, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 24, 2022 EXRA
SOU EXTENSION 3 GRANTED
Sep 22, 2022 EX3G
SOU EXTENSION 3 FILED
Sep 22, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 22, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 30, 2022 EXRA
SOU EXTENSION 2 GRANTED
Mar 28, 2022 EX2G
SOU EXTENSION 2 FILED
Mar 28, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 28, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 29, 2021 EXRA
SOU EXTENSION 1 GRANTED
Sep 27, 2021 EX1G
SOU EXTENSION 1 FILED
Sep 27, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 27, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 25, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 30, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 30, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 22, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 5, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 5, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 5, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 5, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2020 NWOS
NEW APPLICATION ENTERED
Jul 3, 2020 NWAP

Related Trademarks

More from this Owner

OPSIS THERAPEUTICS

OPSIS THERAPEUTICS

OPSIS THERAPEUTICS

OPSIS THERAPEUTICS